Status:
COMPLETED
Study on the Safety and Effects on Lipids of FM-VP4 in Subjects With Primary Hypercholesterolemia
Lead Sponsor:
Forbes Medi-Tech
Conditions:
Hypercholesterolemia
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
Brief Summary
The purpose of this study is to evaluate the safety and effects on lipids of FM-VP4 administered for 12 weeks in subjects with mild to moderate primary hypercholesterolemia.
Eligibility Criteria
Inclusion
- Mild to moderate primary hypercholesterolemia
- Able to give informed consent and to comply with study procedures (including diet)
Exclusion
- Homozygous familial hypercholesterolemia
- Age \<18 or \>75 years
- Pregnant women or women of child-bearing potential
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT00293878
Start Date
November 1 2005
Last Update
February 26 2007
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
Coastal Clinical Research
Mobile, Alabama, United States, 36608
2
Radiant Research
San Diego, California, United States, 92123
3
Radiant Research
Daytona Beach, Florida, United States, 32114
4
Radiant Research
Gainesville, Florida, United States, 32605